Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals

BACKGROUND: Clearance of hepatitis C virus (HCV) can potentially slow or reverse liver fibrosis and cirrhosis. Studies of fibrosis changes after treatment with direct-acting antivirals (DAAs) are limited. OBJECTIVES: We aimed to assess the impact of DAAs on fibrosis in HCV treatment responders. DESI...

Descripción completa

Detalles Bibliográficos
Autores principales: Alswat, Khalid, Al-Sohaibani, Fahad, Khathlan, Abdullah, Bashmail, Ahmad, Alanazi, Mohammed, Kurdi, Amr, Almakadma, Abdul Hakim, Al-hamoudi, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981998/
https://www.ncbi.nlm.nih.gov/pubmed/35380056
http://dx.doi.org/10.5144/0256-4947.2022.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981998/
https://www.ncbi.nlm.nih.gov/pubmed/35380056
http://dx.doi.org/10.5144/0256-4947.2022.89

Ejemplares similares